Avizakimab

• Target :

  Interleukin

• Related Pathways :

  Immunology/Inflammation

• Purity :

  1

• Bioactivity :

  Avizakimab (BOS161721) is a humanized lgG1 monoclonal antibody that targets and inhibits the biological activity of IL-21, with potential for the treatment of systemic lupus erythematosus (SLE) .

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2229685-51-0